121 related articles for article (PubMed ID: 6345162)
1. Detection of circulating immune complexes in gynecological malignancies.
Neri B; Comparini T; Brogioni M; Chieffi O; Fabbiani M
Eur J Gynaecol Oncol; 1983; 4(1):37-40. PubMed ID: 6345162
[TBL] [Abstract][Full Text] [Related]
2. Circulating IgG-specific immune complexes as a potential tumor marker in gynecological malignancies.
Dodd JK; Hicks LJ; Tyler JP; Crandon AJ; Hudson CN
Gynecol Oncol; 1983 Oct; 16(2):232-9. PubMed ID: 6629124
[TBL] [Abstract][Full Text] [Related]
3. Sequential studies of circulating immune complexes in gynecological malignancies.
Poulton TA; Crowther ME; Nineham LJ; Mooney NA; Hay FC
Am J Reprod Immunol (1980); 1982 Oct; 2(5):265-9. PubMed ID: 7180950
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of immune complexes detectable by two independent assays in gynaecological malignancies.
Poulton TA; Mooney NA; Nineham LJ; Hay FC
Clin Exp Immunol; 1983 Sep; 53(3):573-80. PubMed ID: 6604605
[TBL] [Abstract][Full Text] [Related]
5. [Characteristics of the immunological status of endometriosis patients].
Suprun LIa
Akush Ginekol (Mosk); 1983 Feb; (2):41-4. PubMed ID: 6601920
[No Abstract] [Full Text] [Related]
6. [Importance of CA-50 detection in malignant gynecologic tumors].
Indraccolo SR; Greco A; Cartechini MG; Compagnucci P
Minerva Ginecol; 1990 Dec; 42(12):507-9. PubMed ID: 2089292
[TBL] [Abstract][Full Text] [Related]
7. [Prospects of the use of neoplasm antigens as markers of gynecologic diseases].
Adamian LV; Fanchenko ND; Andreeva EN; Novikov EA; Alekseeva ML
Sov Med; 1990; (6):26-9. PubMed ID: 2204116
[TBL] [Abstract][Full Text] [Related]
8. [Detection of CA-125 antigen (non-mucinous ovarian cancer antigen)-- in serum of patients with gynecological malignancies].
Sakamoto S; Kawana H; Shimizu K; Ishihara T; Ueda K; Usman SM; Uchida S; Kawagoe K; Kihara K; Kubo H
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Aug; 36(8):1261-2. PubMed ID: 6595322
[No Abstract] [Full Text] [Related]
9. Clinical evaluations of the tumor marker sialyl SSEA-1 antigen for clinical gynecological disease.
Iwanari O; Miyako J; Date Y; Nakayama S; Kijima S; Moriyama M; Karino K; Endoh J; Kitao M
Gynecol Obstet Invest; 1990; 29(3):214-8. PubMed ID: 1972688
[TBL] [Abstract][Full Text] [Related]
10. Levels of circulating immune complexes in patients with ovarian cancer.
Clarke AG; Vasey DP; Symonds EM; Faratian B; McLaughlin PJ; Price MR; Baldwin RW
Br J Obstet Gynaecol; 1982 Mar; 89(3):231-7. PubMed ID: 7066260
[TBL] [Abstract][Full Text] [Related]
11. The value of the monoclonal antibody (cancer antigen 125) in serial monitoring of ovarian cancer: a comparison with circulating immune complexes.
Dodd J; Tyler JP; Crandon AJ; Blumenthal NJ; Fay RA; Baird PJ; Hicks LJ; Hudson CN
Br J Obstet Gynaecol; 1985 Oct; 92(10):1054-60. PubMed ID: 3863669
[TBL] [Abstract][Full Text] [Related]
12. Immune complexes in ovarian carcinoma.
Runowicz CD; Cohen CJ; Adelsberg BR
Gynecol Oncol; 1989 Mar; 32(3):350-3. PubMed ID: 2920956
[TBL] [Abstract][Full Text] [Related]
13. [Sequential determination of circulating immune complexes in ovarian tumors].
Beaufort F; Auner H; Lahousen M
Wien Med Wochenschr; 1986 Jul; 136(13):317-22. PubMed ID: 3765649
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic usefulness of stepwise discriminant analysis employing the values of CA125, TPA, IAP, CEA and ferritin in sera measured simultaneously for gynecological malignant neoplasms].
Yabushita H; Masuda T; Hattori A; Noguchi M; Ito Y; Nakanishi M; Ishihara M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1883-92. PubMed ID: 2997349
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of sialyl SSEA-1 antigen in patients with ovarian cancer.
Suzuki M; Ohwada M; Tamada T
Gynecol Oncol; 1990 Mar; 36(3):371-5. PubMed ID: 1969379
[TBL] [Abstract][Full Text] [Related]
16. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers].
Suzumori K; Yasui Y; Asai H; Hisaoka T; Mizuno K; Yagami Y
Gan No Rinsho; 1985 May; 31(5):544-8. PubMed ID: 3860666
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significances of tissue polypeptide antigen in patients with gynecological malignancies].
Ueda M; Sudo N; Furuya M; Arakawa O; Ikarashi T
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2361-8. PubMed ID: 3001201
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of T.P.A. (tissue polypeptide antigen) in gynecological malignancies.
Restaino A; Fanizza G; Battarino O
Eur J Gynaecol Oncol; 1986; 7(3):183-5. PubMed ID: 3780759
[TBL] [Abstract][Full Text] [Related]
19. Circulating immune complexes as markers of response to chemotherapy in malignant teratomas and gestational trophoblastic tumours.
Begent RH; Chester KA; Walker LC; Tucker DF
Br J Cancer; 1982 Feb; 45(2):217-22. PubMed ID: 6174138
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer].
Kimura E; Murae M; Koga R; Odawara Y; Nakabayashi Y; Yokoyama K; Nakata H; Totake T; Ochiai K; Yasuda M
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2121-8. PubMed ID: 6595320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
